Skip to main content

Table 1 Baseline characteristics of the subjects according to hepatic steatosis (HS) and the metabolic syndrome (MetS)

From: Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome

 

Control

HS alone

HS with MetS

 

Characteristics

(n = 144)

(n = 84)

(n = 46)

P a

Age, y

42.9 ± 7.1

43.7 ± 6.7

45.1 ± 7.9

0.178

Women, %

68.1

47.6

23.9

< 0.001

Smoking, ex- and current, %

26.1

39.3

56.5

< 0.001

Alcohol consumption (≥20 g/d), %

15.3

23.8

45.7

< 0.001

ALT, IU/L

18.4 ± 8.8

24.5 ± 14.1**

37.5 ± 24.5***†

< 0.001

Ferritin, ng/ml

51.7 ± 47.5

74.7 ± 62.3*

131.6 ± 106.3***†

< 0.001

Body mass index, kg/m2

21.8 ± 2.2

24.3 ± 2.3***

26.0 ± 2.1***†

< 0.001

  1. Values are mean ± SD unless noted otherwise. Components of the metabolic syndrome are not expressed. ALT; alanine aminotransferase.
  2. a P values by analysis of variance (ANOVA) or chi-square test for trend.
  3. *P < 0.05, ** P < 0.01, *** P < 0.001; compared with the control (Bonferroni comparison).
  4. † P < 0.001; compared with the HS alone (Bonferroni comparison).
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us